BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33189966)

  • 1. Gross mucinous multinodular appearance aids in the identification of ovarian metastases in low-grade appendiceal mucinous neoplasms during intraoperative consultation.
    Yoshida H; Tanaka H; Tsukada T; Abeto N; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
    Ann Diagn Pathol; 2021 Feb; 50():151641. PubMed ID: 33189966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors.
    Stewart CJ; Ardakani NM; Doherty DA; Young RH
    Int J Gynecol Pathol; 2014 Jan; 33(1):1-10. PubMed ID: 24300528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
    Schmoeckel E; Kirchner T; Mayr D
    Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Discordance in Intraoperative Frozen Section Diagnosis of Ovarian Tumors: A Literature Review and Analysis of 871 Cases Treated at a Japanese Cancer Center.
    Yoshida H; Tanaka H; Tsukada T; Abeto N; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2021 Feb; 29(1):30-38. PubMed ID: 32955372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the necessity for routine appendectomies in mucinous neoplasms of the ovary: An evaluation of 460 mucinous ovarian tumors.
    Albloshi A; Fadare O
    Ann Diagn Pathol; 2022 Aug; 59():151950. PubMed ID: 35439697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication.
    Zhang W; Tan C; Xu M; Wu X
    Eur J Surg Oncol; 2019 Nov; 45(11):2120-2125. PubMed ID: 31462390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.
    Misdraji J; Yantiss RK; Graeme-Cook FM; Balis UJ; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1089-103. PubMed ID: 12883241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms.
    Lavecchia M; Dubey A; Jimenez W; Reade CJ; Salehi A; Yang I; Eiriksson LR
    Int J Gynaecol Obstet; 2024 Jan; 164(1):249-254. PubMed ID: 37485684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complicated appendiceal diverticulosis versus low-grade appendiceal mucinous neoplasms: a major diagnostic dilemma.
    Lowes H; Rowaiye B; Carr NJ; Shepherd NA
    Histopathology; 2019 Oct; 75(4):478-485. PubMed ID: 31166613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
    Meagher NS; Wang L; Rambau PF; Intermaggio MP; Huntsman DG; Wilkens LR; El-Bahrawy MA; Ness RB; Odunsi K; Steed H; Herpel E; Anglesio MS; Zhang B; Lambie N; Swerdlow AJ; Lubiński J; Vierkant RA; Goode EL; Menon U; Toloczko-Grabarek A; Oszurek O; Bilic S; Talhouk A; García-Closas M; Wang Q; Tan A; Farrell R; Kennedy CJ; Jimenez-Linan M; Sundfeldt K; Etter JL; Menkiszak J; Goodman MT; Klonowski P; Leung Y; Winham SJ; Moysich KB; Behrens S; Kluz T; Edwards RP; Gronwald J; Modugno F; Hernandez BY; Chow C; Kelemen LE; Keeney GL; Carney ME; Natanzon Y; Robertson G; Sharma R; Gayther SA; Alsop J; Luk H; Karpinskyj C; Campbell I; Sinn P; Gentry-Maharaj A; Coulson P; Chang-Claude J; Shah M; Widschwendter M; Tang K; Schoemaker MJ; Koziak JM; Cook LS; Brenton JD; Daley F; Kristjansdottir B; Mateoiu C; Larson MC; Harnett PR; Jung A; deFazio A; Gorringe KL; Pharoah PDP; Minoo P; Stewart C; Bathe OF; Gui X; Cohen P; Ramus SJ; Köbel M
    Mod Pathol; 2019 Dec; 32(12):1834-1846. PubMed ID: 31239549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S; Parra-Herran C
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.
    Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P
    Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum.
    Mehta AM; Bignell MB; Alves S; Dayal SP; Mohamed F; Cecil TD; Moran BJ
    Dis Colon Rectum; 2017 Jul; 60(7):691-696. PubMed ID: 28594718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases.
    Vang R; Gown AM; Barry TS; Wheeler DT; Ronnett BM
    Mod Pathol; 2006 Jan; 19(1):97-105. PubMed ID: 16294196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appendiceal mucinous neoplasms: controversial issues.
    Misdraji J
    Arch Pathol Lab Med; 2010 Jun; 134(6):864-70. PubMed ID: 20524864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous tumors of the appendix presenting as primary tumors of the ovary. Report of two cases.
    Liapis A; Michailidis E; Bakas P; Kondi-Pafiti A; Creatasas G
    Eur J Gynaecol Oncol; 2004; 25(1):113-5. PubMed ID: 15053078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.
    Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM
    Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis.
    Cheng A; Li M; Kanis MJ; Xu Y; Zhang Q; Cui B; Jiang J; Zhang Y; Yang X; Kong B
    Gynecol Oncol; 2017 Jan; 144(1):215-222. PubMed ID: 27889016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.
    Ji H; Isacson C; Seidman JD; Kurman RJ; Ronnett BM
    Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.